Visit vs Number of other anti-hypertensives?

	N	Mean	StdDev	Median	Min	Max	Unknown	Total
Baseline	318	0.009	± 0.1	0.0	0.0	1.0	-	318
Final	300	0.01	± 0.1	0.0	0.0	1.0	1	301

Treatment Arm vs Number of other anti-hypertensives?

Baseline

	N	Mean	StdDev	Max	Unknown	Total
Total	318	0.009	± 0.1	1.0	-	318
HLSE	106	0.0	± 0.0	0.0	-	106
HLSE-O	106	0.02	± 0.1	1.0	-	106
HLSE-P	106	0.009	± 0.1	1.0	-	106

Treatment Arm vs Number of other anti-hypertensives?

Final

	N	Mean	StdDev	Max	Unknown	Total
Total	300	0.01	± 0.1	1.0	-	300
HLSE	100	0.0	± 0.0	0.0	-	100
HLSE-O	101	0.02	± 0.1	1.0	-	101
HLSE-P	99	0.02	± 0.1	1.0	-	99

Age vs Number of other anti-hypertensives?

Baseline

	N	Mean	StdDev	Max	Unknown	Total
Total	318	0.009	± 0.1	1.0	-	318
45-54 years	53	0.0	± 0.0	0.0	-	53
55-64 years	139	0.01	± 0.1	1.0	-	139
65-74 years	121	0.008	± 0.09	1.0	-	121
75 or older	5	0.0	± 0.0	0.0	-	5

Age vs Number of other anti-hypertensives?

Final

	N	Mean	StdDev	Max	Unknown	Total
Total	300	0.01	± 0.1	1.0	-	300
45-54 years	49	0.0	± 0.0	0.0	-	49
55-64 years	127	0.02	± 0.1	1.0	-	127
65-74 years	119	0.02	± 0.1	1.0	-	119
75 or older	5	0.0	± 0.0	0.0	-	5

Gender vs Number of other anti-hypertensives?

Baseline

	N	Mean	StdDev	Max	Unknown	Total
Total	318	0.009	± 0.1	1.0	-	318
Male	234	0.004	± 0.07	1.0	-	234
Female	84	0.02	± 0.2	1.0	-	84

Gender vs Number of other anti-hypertensives?

Final

	N	Mean	StdDev	Max	Unknown	Total
Total	300	0.01	± 0.1	1.0	1	301
Male	221	0.005	± 0.07	1.0	1	222
Female	79	0.04	± 0.2	1.0	-	79

Race vs Number of other anti-hypertensives?

Baseline

	N	Mean	StdDev	Max	Unknown	Total
Total	318	0.009	± 0.1	1.0	-	318
African American or Black	42	0.05	± 0.2	1.0	-	42
Caucasian	252	0.004	± 0.06	1.0	-	252
Other	24	0.0	± 0.0	0.0	-	24

Race vs Number of other anti-hypertensives?

Final

	N	Mean	StdDev	Max	Unknown	Total
Total	300	0.01	± 0.1	1.0	-	300
African American or Black	40	0.08	± 0.3	1.0	-	40
Caucasian	237	0.004	± 0.06	1.0	-	237
Other	23	0.0	± 0.0	0.0	-	23

Heart Biomarker Evaluation in Apnea Treatment